Stay updated with breaking news from டெசெரா சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VC Daily: Biotechs Seek New Skill Set From Scientists Entering Field morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Flagship Pioneering : Closes $3.4 Billion Capital Pool to Drive Continued Breakthrough Innovations in Human Health and Sustainability marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Dive Brief: David Davidson, a longtime top executive at gene therapy developer Bluebird bio, will join the richly funded biotech startup Tessera Therapeutics as its chief medical and development officer, the latter company announced Wednesday. At Tessera, Davidson will be joined by former Spark Therapeutics and Moderna executive Hari Pujar, who will become chief operating officer, and by Lin Guey, most recently a vice president at Xilio Therapeutics who has been appointed head of rare disease strategy and operations. Launched by Flagship Pioneering last year, Tessera in January raised $230 million to advance its development of a new, more flexible type of genetic medicine, which the company and its venture backer have dubbed gene writing. ....
Tessera Rewrites the Genome Script Using Mobile Genetic Elements genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.